Publications
1.Passive cigarette smoking is a risk factor in cervical neoplasia.
Gynecol Oncol. 2004 Apr;93(1):116-20.
Tay SK, Tay KJ
PMID: 15047223 [PubMed - indexed for MEDLINE]
2.Right cholecysto-hepato-choledocho fistula: a new variant of type II Mirizzi syndrome?
Tay KJ, Chung AY
ANZ J Surg. 2007 Sep;77(9):798-9.
PMID: 17685965 [PubMed - indexed for MEDLINE]
3.Is Contrast Enhanced Ultrasound a valid diagnostic tool for renal cell carcinoma in patients with renal impairment?
Tay KJ, Ho H, Low A, Cheng CW
Ann Acad Med Singapore. 2012 Mar;41(3):127-8.
PMID: 22538740 [PubMed - indexed for MEDLINE]
4.Prevailing Attitudes Towards Cancer: A Multicultural Survey in a Tertiary Outpatient Setting
Tay KJ, Nor Azhari BMZ, Cheng CW
Ann Acad Med Singapore. 2013 Oct;42(10):492-8.
PMID:24254235[PubMed - in process]
5.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.
Goh LK, Liem N, Vijayaraghavan A, Chen G, Lim PL, Tay KJ, Chang M, Low JS, Joshi A, Huang HH, Kalaw E, Tan PH, Hsieh WS, Yong WP, Alumkal J, Sim HG.
PLoS One. 2014 Mar 13;9(3):e91666. doi: 10.1371/journal.pone.0091666. eCollection 2014.
PMID:24626295[PubMed - in process]
6.The minimally invasive treatments for benign prostatic hyperplasia.
Lim YW, Tay KJ, Ho SH
Proceedings of Singapore Healthcare. 2014 (23): 65-73
Conference Papers
1.Prevailing attitudes towards cancer – a multicultural survey in a regional urology center.
Tay KJ, Nor Azhari BMZ, Cheng C
Presented as poster at Urofair 2010
2.Is Contrast Enhanced Ultrasound a valid diagnostic tool for renal cell carcinoma in patients with renal impairment?
Tay KJ, Ho H, Low A, Cheng CW
Presented at Urofair 2010 (Oral Clinical Presentation), Duke-NUS Scientific Congress 2010 (Poster) and American Urological Association 2010 (Moderated Poster)
3.Initial Experience with MRgfus Focal Therapy for Low-Risk Prostate
Cancer.
Tay KJ, Cheng C, Kwek JW, Thng CH, Lau W, Ho H, Khoo J, Kanaev SV, Gafton GI, Turkevich VG, Nosov AK
Presented at World Congress of Endourology 2011 (Moderated Poster)
4.Early outcomes of pathological T3 prostate cancer: A comparison of robotic versus open radical prostatectomy
Tay KJ, Sim HG, Ho H, Huang HH, Cheng CW
Presented at Urofair 2012 (Oral Clinical Presentation) and Duke-NUS Scientific Congress 2012 (Poster)
5.Continence outcomes after salvage radiotherapy for biochemical recurrence after radical prostatectomy
Tay KJ, Lim YW, Tan T, Sim HG
Presented at Urofair 2012 (Moderated Poster)
6.The diagnostic and prognostic utility of an epigenetic PHYMA signature in prostate cancer.
Tay KJ, Goh LK, Liem N, Chen G, Lim PL, Chang M, Low J, Joshi A, Geronimo C, Huang HH, Kalaw E, Tan PH, Hsieh Wenson, Yong WP, Alumkal J, Sim HG
Presented at Urofair 2013 (Oral Basic Science Presentation) and 19th Asian Congress of Surgery/ 1st Singhealth Surgical Congress (Basic Science Poster)
7.Robotic transperineal saturation biopsy approximates the “truth” in low-risk prostate cancer.
Tay KJ, Ho H, Huang HH, Law ZW, Koh ZJ, Yuen JS, Cheng CW
Presented at Urofair 2013 (Oral Clinical Presentation)
8.Dynamic Contrast Enhanced and Diffusion Weighted MRI correlate with higher grade prostate cancer with extracapsular extension.
Tay KJ, Yuen JS, Thng CH, Jara-Lazaro AR, Ho H, Law YM, Tan PH, Cheng CW
Presented at Urofair 2013 (Poster)
9.Robotic Transperineal Prostate Biopsy – Technique and outcomes (Video)
Tay KJ, Ho H, Yuen J, Cheng C
Presented at Urofair 2014 and AUA 2014
10.A treatment journey of 108 men on active surveillance for prostate cancer: Why men change?
Tay KJ, Huang HH, Lee LS, Lau W, Cheng C, Yuen J
Presented at Urofair 2014 (Oral Clinical Presentation)
